Articles Tagged With: TIA
-
Benefits and Risks of Dual Antiplatelet Therapy After Acute Ischemic Stroke or TIA
Secondary prevention of acute ischemic stroke is continuing to evolve with great interest in the use of dual antiplatelet treatment early in the course. A complicating factor has been the role of the CYP2C19 loss-of-function gene that interferes with the conversion of clopidogrel to its active antiplatelet metabolite.
-
Which Patients with TIA Are at High Risk for a Recurrent Cerebral Vascular Events?
Recurrent cerebral vascular events are one of the main determinants of outcome in patients after minor strokes and transient ischemic attacks.
-
ICH May Clinically Mimic TIA
In a large retrospective review of 2137 patients with intracerebral hemorrhage, 34 had transient symptoms that could have been misclassified as “transient ischemic attack” if brain imaging had not been performed.